# Analytical Procedures and Methods Validation for Drugs and Biologics - FDA Guidance Document

Source: https://www.keypedia.com/guidances/guidance-document/analytical-procedures-and-methods-validation-for-drugs-and-biologics/09d35164-7a70-4359-b2bc-338524a3d23c

> FDA guidance document: Analytical Procedures and Methods Validation for Drugs and Biologics. Issue date: July 27, 2015. Get complete insights and analysis.

---

## Details

- Title: Analytical Procedures and Methods Validation for Drugs and Biologics
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2015-07-27
- Last Changed: 2020-04-21
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2015-N-0007">FDA-2015-N-0007</a>

## Related Documents

- [Allowable Excess Volume and Labeled Vial Fill Size in Injectable Drug and Biological Products](https://www.keypedia.com/guidances/guidance-document/allowable-excess-volume-and-labeled-vial-fill-size-in-injectable-drug-and-biological-products/5935b91f-6e77-42d4-81df-3b62cf000873)
- [Patient Counseling Information Section of Labeling for Human Prescription Drug and Biological Products — Content and Format](https://www.keypedia.com/guidances/guidance-document/patient-counseling-information-section-of-labeling-for-human-prescription-drug-and-biological-products-content-and-format/91c267ae-e99d-4508-b31c-721b7da25d2b)
- [E2C(R2) Periodic Benefit-Risk Evaluation Report – Questions and Answers](https://www.keypedia.com/guidances/guidance-document/e2cr2-periodic-benefit-risk-evaluation-report-questions-and-answers/9735c0c5-468e-4e9b-a4c9-a7bad1eb9d94)